$100 OFF first month of medication for new clients purchasing 12-month plan
Growth Hormone Peptides NEW

Back

Menu

Treatment Categories

Get Started

Personalized
Testosterone
Treatments

Get started →

Growth Hormone Peptides NEW

GET STARTED

Reduce fat.
Recover faster.
Rejuvenate naturally.

Get started →

GLP-1 weight loss, backed by science.

Sustainable, doctor-guided weight loss — personalized to your goals, shipped discreetly to your door.

Get Started

Compounded and brand-name GLP-1s, in one place.

Compounded

GLP-1 + GIP

Tirzepatide

Discover one of the most effective medical weight loss tools available — clinically studied to support significant weight loss over time.

✓ Proven to lose weight effectively

✓ Custom dosing and ongoing adjustments

✓ Free and discreet shipping

Starting at $249.99/28-day supply

Compounded

GLP-1

Semaglutide

Unlock meaningful weight loss support with Semaglutide — clinically studied to help patients achieve significant results over time.

✓ Proven to lose weight effectively

✓ Custom dosing and ongoing adjustments

✓ Free and discreet shipping

Starting at $149.99/28-day supply

Brand-name

GLP-1

FDA-approved

Foundayo™ Tablets

Foundayo™ (orforglipron) is the only GLP-1 pill for weight loss that can be taken any time of day, with or without food or water restrictions. FDA-approved for chronic weight management in adults with obesity or overweight with a weight-related condition.

Starting at $199.99/mo

Brand-name

GLP-1

FDA-approved

Wegovy® Tablets

Wegovy® tablets deliver the same active ingredient as the Wegovy injection, in a once-daily oral form. The first and only FDA-approved semaglutide pill for weight loss in adults with obesity or overweight with a weight-related condition.

Starting at $249.99/mo

Brand-name

GLP-1

FDA-approved

Zepbound®

Zepbound® (tirzepatide) once-weekly injection. FDA-approved for chronic weight management and for moderate-to-severe obstructive sleep apnea in adults with obesity.

Starting at $449.99/mo

Brand-name

GLP-1

FDA-approved

Wegovy® Pens

Wegovy® once-weekly injection for chronic weight management in adults with obesity with a weight-related condition, and to reduce the risk of major cardiovascular events.

Starting at $349.99/mo

Brand-name

GLP-1

Ozempic®

A once-weekly semaglutide injection that improves insulin sensitivity, reduces appetite, and helps regulate blood sugar.

Starting at $349.99/mo

Brand-name

GLP-1 + GIP

Mounjaro®

A once-weekly tirzepatide injection that activates two hormone receptors — GIP and GLP-1 — to reduce appetite, slow gastric emptying, and support metabolic health.

Starting at $1,249.99/mo

*Maximus clinical study data on Maximus clients

Clinically studied ingredients. Proven results.

Get Started

Body Weight Support (Tirzepatide)

GLP-1 + GIP

Tirzepatide is a dual-action GLP-1 and GIP receptor agonist clinically studied for its ability to support metabolic health and weight management over time. Results vary.

Body Weight Support (Semaglutide)

GLP-1

Semaglutide is a GLP-1 receptor agonist clinically studied for its ability to support appetite control and healthy weight management over time. Results vary. 4.7/5 Reviews

Get Started

Side effects

Contact your provider immediately if you have severe abdominal pain that does not go away (possible pancreatitis); a lump/swelling in your neck, hoarseness, or trouble swallowing (possible thyroid tumor); severe vomiting or diarrhea with signs of dehydration; symptoms of low blood sugar; or signs of a serious allergic reaction. Regular monitoring may be needed to track your response to treatment.

COMPOUNDED MEDICATIONS ARE NOT FDA-APPROVED FOR SAFETY, EFFICACY, OR QUALITY.

Common side effects may include:

Nausea; Diarrhea; Vomiting; Constipation; Abdominal pain; Indigestion; Injection-site reactions; Feeling tired; Belching; Hair loss; Fatigue; Heartburn

Rare, but serious side effects may include:

  • Acute pancreatitis (including fatal, hemorrhagic, necrotizing)
  • Acute gallbladder disease
  • Acute kidney injury (typically secondary to dehydration)
  • Severe gastrointestinal disease / delayed gastric emptying
  • Hypoglycemia (especially with insulin or sulfonylureas)
  • Hypersensitivity reactions including anaphylaxis and angioedema
  • Pulmonary aspiration during anesthesia or deep sedation (delayed gastric emptying)
  • Suicidal behavior and ideation (monitor)
  • Diabetic retinopathy complications (in T2D clients with pre-existing retinopathy)
  • Thyroid C-cell tumors (rodent data). Boxed warning class effect: contraindicated in clients with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).

Contact your provider immediately if you have severe abdominal pain that does not go away (possible pancreatitis); a lump/swelling in your neck, hoarseness, or trouble swallowing (possible thyroid tumor); severe vomiting or diarrhea with signs of dehydration; symptoms of low blood sugar; or signs of a serious allergic reaction. Regular monitoring may be needed to track your response to treatment.

COMPOUNDED MEDICATIONS ARE NOT FDA-APPROVED FOR SAFETY, EFFICACY, OR QUALITY.

Nearly 74% of adults in the U.S. are overweight or obese.

Adjust the scale to view your potential weight loss.

Your current weight (lbs):

270

In one year you could lose (lbs):

45

Compounded vs brand-name

Same active ingredient. Different regulatory path.

Compounded

Custom-formulated

Tirzepatide, Semaglutide

  • Regulation: Prepared by licensed US compounding pharmacies. Same active ingredient as brand-name.
  • Cost: $149.99-$249.99 per month, out of pocket. No insurance required.
  • Customization: Dose tailored to you. Vial-and-syringe format.
  • Supply: Reliably in stock through our pharmacy partner.

Brand-name

FDA-approved name brand

Ozempic, Mounjaro, Wegovy, Zepbound, Foundayo

  • Regulation: FDA-approved and manufactured by Novo Nordisk or Eli Lilly.
  • Cost: From $499 per month. Insurance and savings cards may apply.
  • Customization: Fixed doses in pre-filled injection pens.
  • Supply: Subject to manufacturer shortages from time to time.

Both paths are doctor-supervised by Maximus providers. You can switch between compounded and brand-name as your needs change. Compounded medications are not FDA-approved for safety, efficacy, or quality.

Get Started

Optimize your long-term health

GLP-1 medications activate the gut-hormone receptors that regulate appetite, blood sugar, and how full you feel after eating, supporting weight loss when paired with diet and physical activity.

obesity can cause

Type 2 diabetes

Is your health goal now to get your Type 2 diabetes under control?

Start my treatment 

obesity is tied to

Heart Disease

How can we help you decrease your risk of heart disease (including stroke)?

Start my treatment 

obesity can cause

Type 2 diabetes

Is your health goal now to get your Type 2 diabetes under control?

Start my treatment 

Results that speak louder than promises.

I can't say enough good about Maximus. I went from researching weight loss and treatment for low testosterone, to treatment that works, a team that cares, a doctor that spends the time with me, and support mechanisms that matter.

Verified buyer

The month on Tirzepatide was perfect. I wanted to see if it worked before committing long-term. Spoiler: it works. I'm already down two pants sizes and have more energy than I've had in years.

Verified buyer

My doctor told me to lose weight for years. Nothing stuck until Tirzepatide. My energy is back, my blood pressure is down, and I actually feel confident again.

Verified buyer

Collected by Maximus from verified customers. Results vary.

It's easy to get started.

01

Complete your evaluation

Answer a few health questions online. Takes about 5 minutes. No appointment needed, no waiting rooms.

02

Physician review

A board-certified physician reviews your information and determines if tirzepatide is right for you.

03

Treatment delivered

If prescribed, your mediaction ships directly to your door in discreet, unmarked packaging.

Start my treatment

Weight Loss Treatment FAQs

Who is eligible for GLP-1 weight loss treatment?

GLP-1 weight loss medications may be appropriate if you’re trying to lose weight, reduce appetite, improve blood sugar control, or support long-term metabolic health.



After you sign up, a Maximus doctor will review your medical history and determine whether Tirzepatide or Semaglutide is safe and appropriate for you.



If you’re not approved for treatment, you’ll receive a full refund (minus the cost of the doctor consultation).

What states is Weight Loss Protocol available in?

Our Weight Loss Protocol — including Semaglutide and Tirzepatide options — is available nationwide in all states but AL, MS, LA.

Can I use my HSA or FSA card to pay for Weight Loss Protocol?

Yes. Maximus accepts both HSA and FSA cards for weight loss treatment.



Simply enter your HSA/FSA card information at checkout as you would any debit or credit card.



Coverage varies by plan, so if you're unsure whether your HSA/FSA approves GLP-1 medications, check with your plan administrator.

If I’ve previously been prescribed GLP-1 medication, can I start at the same dosage with Maximus?

If you have documentation of prior GLP-1 use, your Maximus provider will help determine the most appropriate dose for your treatment plan.

Do you charge extra for higher doses?

We offer flat-rate monthly plans that include access to all dose tiers.



Your Maximus provider will help you determine the safest and most effective dose for your goals.

What side effects should I be aware of?

Common side effects of GLP-1 medications include:



- Nausea

- Diarrhea

- Vomiting

- Constipation



Side effects are typically mild and temporary. If you experience discomfort, your Maximus doctor may adjust your dosing schedule or recommend supportive strategies.

How long until I see results?

Most people notice:



- Reduced appetite within the first few days

- More stable cravings within 1–2 weeks

- Visible weight loss within several weeks once medication reaches steady-state levels



Results vary based on your dose, metabolism, and adherence to habits like diet and physical activity.

Are GLP-1 medications safe for long-term use?

GLP-1s like Semaglutide and Tirzepatide have been extensively studied for long-term use in weight, metabolic, and diabetes management.



Your Maximus provider will monitor your health markers and adjust your treatment plan as needed.

Can this be used with other Maximus Protocols?

Yes. The Weight Loss Protocol works well alongside other Maximus protocols -including Testosterone, Hair Growth, Blood Flow, and Oxytocin Calming Cream — as part of a comprehensive health optimization plan.



Your provider will ensure there are no contraindications.

Is the Weight Loss Protocol available for both men and women?

Yes — Maximus weight loss treatments are available and effective for both men and women.

Is this compounded with base form or salt form?

Maximus uses only the base form of Semaglutide and Tirzepatide — the same form studied, tested, and approved in clinical trials.



Some pharmacies use salt forms (e.g., “Semaglutide Sodium” or “Semaglutide Acetate”), which are different chemicals, are not equivalent, and have not been tested for safety or effectiveness.



Using salt-form compounds may be unsafe or ineffective.

Prescription grade health care, from anywhere.

Join 50,000+ men and women who have trusted and transformed their health with Maximus.

  • ✓ Easy online doctor visits
  • ✓ No appointments, message anytime
  • ✓ US-based medical providers
  • ✓ Free expedited shipping
Get Started
1
Weight loss, whether achieved by lifestyle intervention, pharmacotherapy, or bariatric surgery, is highly effective as a primary interventional strategy in both the prevention and treatment of type 2 diabetes. In high-risk patients with prediabetes and/or metabolic syndrome, weight loss effectively prevents progression to type 2 diabetes mellitus (T2DM) and improves cardiovascular risk factors.
2
Intentional weight loss, accomplished through behavioral weight loss and exercise, improves insulin sensitivity and associated cardio-metabolic risk factors such as lipid measures, blood pressure, measures of inflammation and vascular function both in healthy individuals and patients with CHD. Additionally, physical fitness, physical function and quality of life all improve.
3
According to IARC data, high BMI index may be the cause of up to half a million cancer cases per year. In addition, overweight and obesity contribute to increased mortality due to malignancies - it is estimated that they are the cause of death in 20% of women and in 14% of men. Data from the American Cancer Society indicate increased mortality due to pancreatic cancer, liver cancer, multiple myeloma, and Hodgkin's lymphoma in connection with the occurrence of excessive body weight.
4
In the SELECT cardiovascular outcomes trial, semaglutide showed a 20% reduction in major adverse cardiovascular events in 17,604 adults with preexisting cardiovascular disease, overweight or obesity, without diabetes.